Clinical response to bevacizumab in schwannomatosis.

Jaishri Blakeley; Karisa C Schreck; D Gareth Evans; Bruce R Korf; David Zagzag; Matthias A Karajannis; Amanda L Bergner; Allan J Belzberg

doi:10.1212/WNL.0000000000000997

Clinical response to bevacizumab in schwannomatosis.

Jaishri Blakeley, Karisa C Schreck, D Gareth Evans, Bruce R Korf, David Zagzag, Matthias A Karajannis, Amanda L Bergner, Allan J Belzberg

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Neurology
DOIs	https://doi.org/10.1212/WNL.0000000000000997
Publication status	Published - 22 Oct 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1212/WNL.0000000000000997

Cite this

@article{254420bbeec94d4fbaa7e095b35bddfb,

title = "Clinical response to bevacizumab in schwannomatosis.",

author = "Jaishri Blakeley and Schreck, {Karisa C} and Evans, {D Gareth} and Korf, {Bruce R} and David Zagzag and Karajannis, {Matthias A} and Bergner, {Amanda L} and Belzberg, {Allan J}",

year = "2014",

month = oct,

day = "22",

doi = "10.1212/WNL.0000000000000997",

language = "English",

journal = "Neurology",

issn = "1526-632X",

publisher = "Lippincott Williams & Wilkins",

}

TY - JOUR

T1 - Clinical response to bevacizumab in schwannomatosis.

AU - Blakeley, Jaishri

AU - Schreck, Karisa C

AU - Evans, D Gareth

AU - Korf, Bruce R

AU - Zagzag, David

AU - Karajannis, Matthias A

AU - Bergner, Amanda L

AU - Belzberg, Allan J

PY - 2014/10/22

Y1 - 2014/10/22

U2 - 10.1212/WNL.0000000000000997

DO - 10.1212/WNL.0000000000000997

M3 - Article

C2 - 25339217

SN - 1526-632X

JO - Neurology

JF - Neurology

ER -